Navigation Links
Neisseria meningitidis disseminates itself by sending out 'scouts'
Date:2/17/2011

Although, in the majority of cases, the localized presence of Neisseria meningitidis in the throat has no consequence, it can sometimes lead to meningitis or septicaemia. The seriousness of these two infections is driving researchers from around the world to improve their understanding of the mode of operation of this bacterium, which, once it leaves its favourite location (the throat) becomes extremely dangerous. The Avenir team directed by Guillaume Dumnil within Inserm Mixed Research Unit 970, "Paris centre de recherche cardiovasculaire" at the Universit Paris Descartes, has recently discovered how this bacterium disseminates, leaving the throat to pass into the bloodstream. The results of this research have been published in the 11 February 2011 issue of the journal, Science. Neisseria meningitidis is a bacterium specific to man. It is frequently present in the non-pathogenic state in the throat of healthy carriers (5% to 30% of the population).

Its persistence in the organism can however prove dangerous in some cases. The location where the bacteria multiply, the throat, represents a port of entry, from where it disseminates into the bloodstream and may penetrate into the brain. In both these cases, the infection becomes very serious since it results in septicaemia or meningitis. Unless dealt with quickly, the mortality rate linked to these two infections is very high.

Guillaume Dumnil and his Inserm research team were, therefore, interested to understand more about this bacterium which, when it passes into the bloodstream, becomes very dangerous. "Certain advances made in the past few years provided the starting point for this work, which is published in Science", he explained. We know, for example, that Neisseria meningitidis are equipped with special structures known as pili. These allow the bacteria to adhere to the cells of the throat and to multiply and form aggregates there. We are closely studying
'/>"/>

Contact: Sverine Ciancia
severine.ciancia@inserm.fr
33-144-236-086
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Scripps scientists develop first examples of RNA that replicates itself indefinitely
2. Scientists discover how deadly fungus protects itself
3. Biodiversity itself begets a species cascade, researchers say
4. No longer a gray area: Our hair bleaches itself as we grow older
5. A window that washes itself?
6. Your body recycling itself -- captured on film
7. Wildflower armors itself against disease
8. Africa can feed itself in a generation: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2015)... , Aug. 19, 2015  VOXX International Corporation ... has entered into a Definitive Agreement to purchase ... iris authentication market leader EyeLock through an acquiring ... have a controlling interest in the acquiring entity. ... completion of due diligence.  Expanding on its existing ...
(Date:8/12/2015)... Minn. , Aug. 12, 2015   MedNet ... supports the entire spectrum of clinical research, is proud ... , the company,s comprehensive SaaS-based eClinical technology platform, has ... during the first two quarters of 2015.   Q2 ... second largest quarters measured by contract value sold in ...
(Date:8/11/2015)... Today, ZUK announced its Android smartphone Z1, ... expected revenues in 2015 that relate to sales of FPC1155 for ... approximately 2,200 MSEK for 2015. Jörgen Lantto, CEO of ... smartphone manufacturer in China and ... 155 for Z1 , ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5MedNet Solutions Experiences Explosive Corporate Growth 2FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
... This release is available in German . ... To defend themselves, they have developed sophisticated chemical defense ... cress ( Arabidopsis thaliana ), produce glucosinolates (mustard oil ... different kinds of these molecules; they have a similar ...
... such as the Japan earthquake can be revealed in ... to a psychology expert at Queen Mary, University of ... Mary, University of London, and author of Controlling Uncertainty: ... had a devastating immediate effect on tens of thousands ...
... Using skin cells from adult siblings with schizophrenia and ... researchers have created induced pluripotent stem cells (iPS cells) using ... February 22 in Molecular Psychiatry , the team confirms ... mutations in the gene named Disrupted In Schizophrenia 1, or ...
Cached Biology News:Production of mustard oils: On the origin of an enzyme 2Production of mustard oils: On the origin of an enzyme 3Psychological impact of Japan disaster will be felt 'for some time to come' 2Johns Hopkins team creates stem cells from schizophrenia patients 2Johns Hopkins team creates stem cells from schizophrenia patients 3
(Date:8/27/2015)... , ... August 27, 2015 , ... ... for venture capital funds, investment firms and animal health companies to hear from ... raised $160 million. Several have also received licensing agreements or distribution contracts. ...
(Date:8/27/2015)... Aug. 27, 2015  Neogen Corporation (NASDAQ: NEOG ... of United Kingdom -based Lab M ... media and diagnostic systems. Lab M ... leading provider of microbial testing and diagnostic products for ... The company currently sells into more than 70 countries ...
(Date:8/27/2015)... CELEBRATION, Fla. , Aug. 27, 2015 ... announced that a patient,s eyes—and life—were saved by doctors ... , working with NNFF, NovaBay Pharmaceuticals and Dr. ... Wound Care Center at Seton Medical Center in ... The successful treatment used a breakthrough approach, pioneered by ...
(Date:8/27/2015)... - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced ... 2015. Biorem,s complete second quarter financial statements and MD&A have been ... except earnings per shareThree-months ended , Six -months endedJune 30 , ... , 2014 Revenue , 4,709 , ... , 1,656 , 56 , 3,188 ...
Breaking Biology Technology:VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Neogen acquires U.K.-based Lab M Holdings 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 3BIOREM Reports $718,000 Net Earnings for the Second Quarter 2BIOREM Reports $718,000 Net Earnings for the Second Quarter 3
... FRANCISCO, Calif., May 8 Anesiva,Inc. (Nasdaq: ... and accomplishments,for the first quarter ended March ... its,commercialization activities for FDA-approved Zingo(TM) (lidocaine,hydrochloride monohydrate) ... development milestones for Adlea(TM), the company,s long-acting,localized, ...
... Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP), a ... to participate in the Bank of America,2008 Health ... in Las Vegas,Nevada., Dr. William Hunter, Angiotech,s ... on Wednesday, May 14, beginning at approximately,4:00 pm ...
... highlights Volcano commitment to intravascular imaging ... opens up new clinical and research applications, ... Corporation (Nasdaq: VOLC ), a leading manufacturer ... and Optical,Coherence Tomography (OCT) products designed to enhance ...
Cached Biology Technology:Anesiva Announces First Quarter 2008 Financial Results 2Anesiva Announces First Quarter 2008 Financial Results 3Anesiva Announces First Quarter 2008 Financial Results 4Anesiva Announces First Quarter 2008 Financial Results 5Anesiva Announces First Quarter 2008 Financial Results 6Anesiva Announces First Quarter 2008 Financial Results 7Anesiva Announces First Quarter 2008 Financial Results 8Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter 2Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter 3Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter 4
Anti-Phospho-JKK/SEK1/MKK4 pAb Description: 100 g rabbit polyclonal antibody. Reacts with human/mouse/rat. Tested in WB. Research Focus: signal transduction Storage: -20C Shipping Tem...
...
... pH This pH 9.9 solution is ... immunohistochemical staining procedures. It is for use ... glass slides. For particular antigens, target retrieval ... It should be noted that also endogenous ...
... very potent Rnase free Ribonuclease ... a broad range of temperatures ... does not inhibit SP6, T7, ... and M-MLV reverse transcriptase or ...
Biology Products: